Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-20

Clinical Trial Update: Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a telecoaching program to boost physical activity in patients with chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: COPD | Phase 4 | Status: WITHDRAWN